UBS ASSET MANAGEMENT AMERICAS INC – Vertex Pharmaceuticals Incorporated Transaction History
UBS ASSET MANAGEMENT AMERICAS INC portfolio value:
$914.56M
portfolio value
UBS ASSET MANAGEMENT AMERICAS INC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.17% | 36.37K shares | 34.73M | $289.54 | 3.15M |
| Q2 2022 | share | Decrease | -0.54% | -17.02K shares | 60.56M | $281.79 | 3.12M |
| Q1 2022 | share | Decrease | -10.67% | -374.89K shares | 47.54M | $260.97 | 3.13M |
| Q4 2021 | share | Increase | +27.38% | 755.37K shares | 271.29M | $222.45 | 3.51M |
| Q3 2021 | share | Increase | +12.53% | 307.20K shares | 6.10M | $181.39 | 2.75M |
| Q2 2021 | share | Increase | +18.46% | 382.12K shares | 49.60M | $201.63 | 2.45M |
| Q1 2021 | share | Decrease | -0.85% | -17.64K shares | -48.56M | $214.89 | 2.06M |
| Q4 2020 | share | Increase | +29.31% | 473.12K shares | 54.06M | $236.34 | 2.08M |
| Q3 2020 | share | Increase | +3.89% | 60.49K shares | -11.79M | $272.12 | 1.61M |
| Q2 2020 | share | Increase | +10.70% | 150.22K shares | 117.08M | $290.31 | 1.55M |
| Q1 2020 | share | Increase | +3.43% | 46.49K shares | 36.84M | $237.95 | 1.40M |
| Q4 2019 | share | Decrease | -2.03% | -28.05K shares | 62.45M | $218.95 | 1.35M |
| Q3 2019 | share | Decrease | -0.62% | -8.71K shares | -20.93M | $169.42 | 1.38M |
| Q2 2019 | share | Increase | +2.70% | 36.66K shares | 5.94M | $183.38 | 1.39M |
| Q1 2019 | share | Decrease | -0.19% | -2.53K shares | 24.32M | $183.95 | 1.35M |
| Q4 2018 | share | Increase | +2.77% | 36.63K shares | -29.68M | $165.71 | 1.35M |
| Q3 2018 | share | Decrease | -2.72% | -36.92K shares | 23.85M | $192.74 | 1.32M |
| Q2 2018 | share | Increase | +10.46% | 128.77K shares | 30.47M | $169.96 | 1.35M |
| Q1 2018 | share | Decrease | -0.87% | -10.74K shares | 14.53M | $162.98 | 1.23M |
| Q4 2017 | share | Increase | +11.09% | 123.99K shares | 16.14M | $149.86 | 1.24M |
| Q3 2017 | share | Decrease | -4.81% | -56.46K shares | 18.62M | $152.04 | 1.11M |
| Q2 2017 | share | Decrease | -14.09% | -192.56K shares | 1.86M | $128.87 | 1.17M |
| Q1 2017 | share | Decrease | -38.90% | -869.98K shares | -15.32M | $109.35 | 1.36M |
| Q4 2016 | share | Decrease | -19.41% | -538.58K shares | -77.25M | $73.67 | 2.23M |
| Q3 2016 | share | Decrease | -0.12% | -3.33K shares | 3.01M | $87.21 | 2.77M |
| Q2 2016 | share | Decrease | -5.93% | -175.04K shares | 4.22M | $86.02 | 2.77M |
| Q1 2016 | share | Increase | +1.76% | 50.97K shares | -130.46M | $79.49 | 2.95M |